Non-invasive Prenatal Testing Market
Non-invasive Prenatal Testing Market Size, Share & Trends Analysis Report
Non-invasive Prenatal Testing Market Size, Share, Statistics & Trends Analysis By Product (Products, Consumables, Assay Kits and Reagents, Disposables, Instruments, NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Other Instruments, Services) By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests) By Application (Trisomy, Microdeletion Syndrome, Other Applications) By Test Type (Materni21, Harmony, Panorama, Verify, NIFTY) By Technology (NGS, WGS) By End-User (Diagnostic Laboratories, Hospitals) Other Based On Region, And Segment Forecasts, 2025 – 2031
Published
Report ID : BMRC 9855
Number of pages : 300
Published Date : Jun 2025
Category : Healthcare
Delivery Timeline : 48 hrs
Market Segmentation
By Product
- Products
- Consumables
- Assay Kits and Reagents
- Disposables
- Instruments
- NGS Systems
- PCR Instruments
- Microarrays
- Ultrasound Devices
- Other Instruments
- Services
By Method
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-free DNA in Maternal Plasma Tests
- By Application
- Trisomy
- Microdeletion Syndrome
- Other Applications
By Test Type
- Materni21
- Harmony
- Panorama
- Verify
- NIFTY
- Others
By Technology
- NGS
- WGS
- Others
By End-User
- Diagnostic Laboratories
- Hospitals
Key Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- General Electric
- BGI Group
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- Laboratory Corporation of America Holdings
- Natera, Inc.
- Yourgene Health
- Eurofins LifeCodexx GmbH
- Quest Diagnostics Incorporated
- Myriad Genetics Inc.
- NIPD Genetics
- Next Biosciences
SUMMARY
Segments
Market Segmentation
By Product
- Products
- Consumables
- Assay Kits and Reagents
- Disposables
- Instruments
- NGS Systems
- PCR Instruments
- Microarrays
- Ultrasound Devices
- Other Instruments
- Services
By Method
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-free DNA in Maternal Plasma Tests
- By Application
- Trisomy
- Microdeletion Syndrome
- Other Applications
By Test Type
- Materni21
- Harmony
- Panorama
- Verify
- NIFTY
- Others
By Technology
- NGS
- WGS
- Others
By End-User
- Diagnostic Laboratories
- Hospitals
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- General Electric
- BGI Group
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- Laboratory Corporation of America Holdings
- Natera, Inc.
- Yourgene Health
- Eurofins LifeCodexx GmbH
- Quest Diagnostics Incorporated
- Myriad Genetics Inc.
- NIPD Genetics
- Next Biosciences
